Ethiopathogenesis of autoimmune diabetes mellitus in humans. A review

Central-European Journal of Immunology

Volumn 31, Issue 3-4, 2006, Pages 102-110

  Kantárová, Daniela ^a,d   Buc, Milan ^b   Stuchlíková, Martina ^b   Mokáň, Marián ^a   Vrlík, Mojmír ^c  

^a Faculty of Natural Sciences   (Slovakia)

^b Bratislava   (Slovakia)

^c Martin Centre of Immunology   (Slovakia)

^d FACULTY HOSPITAL   (Slovakia)

Author keywords

Autoantibodies; Autoreactive T cells; HLA alleles; IDDM; Viruses

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN A; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G1; INSULIN; PROINSULIN; TOLL LIKE RECEPTOR;

AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELLULAR IMMUNITY; DIETARY INTAKE; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEREDITY; HUMAN; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

EID: 34247590326     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Robles DT, Eisenbarth GS: Diabetes and related autoimmune diseases. In: Clinical Imunology, Principles and Practice. Ed. RR Rich. Mosby. London, Edinburg, New York, Philadelphia, St. Louis, Sydney, Toronto. 2001, 82.1-82.18.
2. Rewers M (1991): The changing face of the epidemiology of insulin-dependent diabetes mellitus (TDDM): research designs and models of disease causation. Ann Med 23: 419-426.
3. Libman I, Songer T, LaPorte R (1993): How many people in the U.S. have IDDM? Diabetes Care 16: 841-842.
4. Devendra D, Liu E, Eisenbarth GS (2004): Type 1 diabetes: recent developments. BMJ 328: 750-754.
5. Pugliese A (2004): Genetics of type 1diabetes. Endocrinol Metab Clin North Am 33: 1-16.
6. Onkamo P, Vaananen S, Karvonen M, et al. (1999): Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia 42: 1395-1403.
7. Bao F, Yu L, Babu S, et al. (1999): One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 13: 143-148.
8. Hoffenberg EJ, Bao F, Eisenbarth GS, et al. (2000): Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr 137: 356-360.
9. Pinhas-Hamiel O, Dolan LM, Daniels SR, et al. (1996): Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 128: 591.
10. Acton RT: The major histocompatibility complex. In: Clinical Immunology. Principles and Practice. Ed. RR Rich. Mosby. London, Edinburg, New York, Philadelphia, St. Louis, Sydney, Toronto. 2001, 6.1-6.13.
11. Mordes JP, Greiner DL, Rossini AA: Animal models of autoimmune diabetes mellitus. In: Diabetes mellitus: a fundamental and clinical text. Ed. D LeRoith, SI Taylor, JM Olefsky. Lippincott-Raven. Philadelphia. 1996, 349-360.
12. Bach JF (2002): The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347: 911-920.
13. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes Epidemiology Research International Group (1988): Diabetes 37: 1113-1119.
14. Green A, Gale EA, Patterson CC (1992): Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet 339: 905-909.
15. Karvonen M, Vuk-Kajander M, Moltchanova E, et al. (2000): Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23: 1516-1526.
16. Gale EA, Gillespie KM (2001): Diabetes and gender. Diabetologia 44: 3-15.
17. Vandewalle CL, Coeckelberghs MI, De Leeuw IH, et al. (1997): Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry. Diabetes Care 20: 1556-1561.
18. Maier LM, Wicker LS (2005): Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 17: 601-608.
19. Kantarova D, Buc M (2006): Genetic susceptibility to type 1 diabetes mellitus in humans. Physiol Res, in press.
20. Concannon P, Erlich HA, Julier C, et al. (2005): Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 54: 2995-3001.
21. Buc M (1993): The major histocompatibility complex in man. Folia Biol (Prague) 39: 223-242.
22. Buc M: Autoimmunity and autoimmune diseases. Veda, Bratislava. 2005 [in Slovak].
23. Zalkovicova M, Buc M, Niks M, et al. (1988): Genetic determination of phagocytic activity of polymorphonuclear leucocytes. Folia Biol (Praha) 34: 240-247.
24. Chowdhury TA, Mijovic CH, Barnett AH (1999): The aetiology of Type I diabetes. Clin Baillieres Best Pract Res Clin Endocrinol Metab 13: 181-195.
25. Nepom GT: HLA and type I diabetes. In: HLA in health and disease. Ed. R Lechler, A Warrens. Academic Press. New York, Boston, London, Sydney, Tokyo, San Diego, San Francisco. 2000, 231-237.
26. Buc M, Bucova M, Javor J, et al. (2006): Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population. Endocr Regul 40: 1-6.
27. Redondo MJ, Kawasaki E, Mulgrew CL, et al. (2000): DR-and DQ-associated protection from type 1A diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602*. J Clin Endocrinol Metab 85: 3793-3797.
28. Greenbaum CJ, Gaur LK, Noble JA (2002): ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR types. J Autoimmun18: 67-70.
29. Noble JA, Valdes AM, Thomson G, et al. (2000): The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 49: 121-125.
30. Valdes AM, Noble JA, Genin E, et al. (2001): Modeling of HLA class II susceptibility to type I diabetes reveals an effect associated with DPB1. Genet Epidemiol 21: 212-223.
31. Stuchlikova M, Kantarova D, Michalkova D, et al. (2006): Association of HLA-DPB1 alleles with type I diabetes mellitus in Slovak population. Bratisl Lek Listy 107: 73-75.
32. Bennet ST, Lucassen AM, Gough SC, et al. (1995): Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 9: 284-292.
33. Barrat BJ, Payne F, Lowe CE, Hermann R, et al. (2004): Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 53: 1884-1889.
34. Kristiansen OP, Larsen ZM, Pociot F (2000): CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 1: 170-184.
35. Ueda H, Howson JM, Esposito L, et al. (2003): Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
36. Paust S, Lu L, McCarty N, Cantor H (2004): Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA 101: 10398-10403.
37. Bottini N, Musumeci L, Alonso A, et al. (2004): A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36: 337-338.
38. Smyth D, Cooper JD, Collins JE, et al. (2004): Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53: 3020-3023.
39. Vella A, Cooper JD, Lowe CE, et al. (2005): Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76: 773-779.
40. Nakagawa Y, Kawaguchi Y, Twells RC, et al. (1998): Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. Am J Hum Genet 63: 547-556.
41. Esposito L, Hill NJ, Pritchard LE, et al. (1998): Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. IMDIAB Group. Diabetes 47: 1797-1799.
42. Copeman JB, Cucca F, Hearne CM, et al. (1995): Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 9: 80-85.
43. Bergholdt R, Ghandil P, Johannesen J, et al. (2004): Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. J Med Genet 41: e39.
44. Bucova M (2002): Role of cytokines of local and systemic inflammation and septic shock. Vnitr Lek 48: 755-762.
45. Kristiansen OP, Karlsen AE, Larsen ZM, et al. (2004): Identification of a type 1 diabetes-associated CD4 promoter haplotype with high constitutive activity. Scand J Immunol 59: 582-591.
46. Buc M, Shawkatova I (2002): Immunopathogenesis of type 1A diabetes mellitus. Czech-Slovak Pediatry 57: 299-305 [in Slovak].
47. Honeyman M (2005): How robust is the evidence for viruses in the induction of type 1 diabetes? Curr Opin Immunol 17: 616-623.
48. Forrest JM, Menser MA, Harley JD (1969): Diabetes mellitus and congenital rubella. Pediatrics 44: 445-447.
49. Menser MA, Forrest JM, Bransby RD (1978): Rubella infection and diabetes mellitus. Lancet 1: 57-60.
50. Hummel M, Fuchtenbusch M, Schenker M, et al. (2000): No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care 23: 969-974.
51. Hyoty H, Leinikki P, Reunanen A, et al. (1988): Mumps infections in the etiology of type 1 (insulin-dependent) diabetes. Diabetes Res 9: 111-116.
52. Parkkonen P, Hyoty H, Koskinen L, et al. (1992): Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules. Diabetologia 35: 63-69.
53. Hyoty H, Hiltunen M, Reunanen A, et al. (1993): Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group. Diabetologia 36: 1303-1308.
54. Honeyman MC, Stone NL, Harrison LC (1998): T-cell epitopes on type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med 4: 231-239.
55. Salminen K, Sadeharju K, Lonnrot M, et al. (2003): Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 69: 91-98.
56. Yoon JW, Austin M, Onodera T, et al. (1979): Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300: 1173-1179.
57. Kukreja A, Maclaren NK (1999): Autoimmunity and diabetes. J Clin Endocrinol Metab 84: 4371-4378.
58. Horwitz MS, Bradley LM, Harbertson J, et al. (1998): Diabetes induced by Coxsackie virus: inition by bystander damage and not molecular mimicry Nat Med 4: 781-785.
59. Heino L, Lonnrot M, Knip P, et al. (2001): No evidence of abnormal regulation of antibody response to coxsackievirus B4 antigen in prediabetic children. Clin Exp Immunol 126: 432-436.
60. Sandor F, Buc M (2005): Toll-like receptors I. Structure, function and their ligands. Folia Biol (Praha) 51: 148-157.
61. Wen L, Peng J, Li Z, et al. (2004): The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J Immunol 172: 3173-3180.
62. Zipris D, Lien E, Xie JX, et al. (2005): TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 174: 131-142.
63. Martin JM, Trink B, Daneman D, et al. (1991): Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM). Ann Med 23: 447-452.
64. Wills-Karp M, Santeliz J, Karp CL (2001): The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1: 69-75.
65. Haskins K, Bradley B, Powers K, et al. (2003): Oxidative stress in type 1 diabetes. Ann NY Acad Sci 1005: 43-54.
66. Wu Q, Salomon B, Chen M, et al. (2001): Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J Exp Med 193: 1327-1332.
67. Gommerman JL, Browning JL (2003): Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 3: 642-655.
68. Hoglund P, Mintern J, Waltzinger C, et al. (1999): Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189: 331-339.
69. Harrison LC, Schmidli RS, Petrovsky N, et al. Insulin-dependent diabetes mellitus In: Clinical Immunology. Ed. J Bradley, J McCluskey. Oxford Univ Press. Oxford, New York, Melbourne. 1997, 147-159.
70. Godfrey DI, Hammond KJ, Poulton LD, et al. (2000): NKT cells: facts, functions and fallacies. Immunol Today 21: 573-583.
71. Godfrey DI, Kinder SJ, Silvera P, et al. (1997): Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8- thymocytes. J Autoimmun 10: 279-285.
72. Baxter AG, Kinder SJ, Hammond KJ, et al. (1997): Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46: 572-582.
73. Wilson SB, Kent SC, Patton KT, et al. (1998): Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391: 177-181.
74. Muir A, Maclaren N: Insulin-dependent diabetes mellitus, human. In: Encyclopedia of Immunology. Ed. PJ Delves, IM Roitt. Academic Press. San Diego, London, Boston, New York, Sydney, Tokyo, Toronto. 1998, 1399-1404.
75. Notions AL (2004): Type 1 diabetes as a model for autoantibodies as predictors of autoimmune diseases. Autoimmun Rev 3 Suppl 1: S7-S9.
76. Mahon JL, Dupre J, Stiller CR (1993): Lessons learned from use of cyclosporine for insulin-dependent diabetes mellitus. The case for immunotherapy for insulin-dependent diabetics having residual insulin secretion. Ann NY Acad Sci 696: 351-363.
77. Levisetti MG, Suri A, Frederick K, et al. (2004): Absence of lymph nodes in NOD mice treated with lymphotoxin-beta receptor immunoglobulin protects from diabetes. Diabetes 53: 3115-3119.
78. Van Kaer L (2005): alphaGalactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol 5: 31-42.
79. Bresson D, Togher L, Rodrigo E, et al. (2006): Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Invest 116: 1371-1381.